Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Inv. presentation
AtriCure, Inc. (ATRC) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/02/2022 8-K Investor presentation, Quarterly results
Docs: "AtriCure Reports Second Quarter 2022 Financial Results",
"Forward Looking Statements This"
05/03/2022 8-K Quarterly results
01/10/2022 8-K Investor presentation
Docs: "AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2021, Provides Financial Outlook for 2022",
"Significant Global Market Opportunity"
08/04/2021 8-K Quarterly results
01/11/2021 8-K Investor presentation
Docs: "Emphasizes value of team-based approach for advanced AF treatment Additive to endocardial catheter ablation Medtronic® is a registered trademark of Medtronic, Inc. Biosense Webster® is a registered trademark of Biosense Webster, Inc. Abbott® is a registered trademark of Abbott Laboratories Inc. Trademarks are not owned by AtriCure and are used for comparative purposes only. © 2021 AtriCure, Inc. All rights reserved. AtriCure 12"
11/05/2020 8-K Investor presentation, Quarterly results
Docs: "FORM 8-K",
"AtriCure Reports Third Quarter 2020 Financial Results • Worldwide revenue of $54.8 million - a decrease of 3.3% year over year • U.S. revenue of $44.7 million - a decrease of 3.1% year over year • International revenue of $10.1 million - a decrease of 4.1% year over year MASON, Ohio, November 5, 2020 - AtriCure, Inc. , a leading innovator in treatments for atrial fibrillation and left atrial appendage management, today announced third quarter 2020 financial results. “We are pleased with our third quarter performance and the improving trajectory of our business, which reflect the commitment of our team and underlying demand in our core markets,” said Michael Carrel, President and Chief Executive Officer of AtriCure. “We are continuing to make significant progress on our strategic initiative...",
"Investor Presentation updated as of November 5, 2020"
04/29/2020 8-K Investor presentation, Quarterly results
Docs: "ACKNOWLEDGMENT OF AMENDMENT AND REAFFIRMATION OF GUARANTY Section 1.Guarantor hereby acknowledges and confirms that it has reviewed and approved the terms and conditions of the Fourth Amendment to Loan and Security Agreement dated as of even date herewith . Section 2.Guarantor hereby consents to the Amendment and agrees that the Guaranty Agreement, dated as of April 9, 2018 and the Security Agreement delivered by Guarantor to Agent, dated as of April 9, 2018 , in each case relating to the Obligations of Borrower under the Loan Agreement shall continue in full force and effect, shall be valid and enforceable and shall not be impaired or otherwise affected by the execution of the Amendment or any other document or instruction delivered in connection herewith. Section 3.Guarantor represents a...",
"AtriCure Reports First Quarter 2020 Financial Results",
"AtriCure Investor Presentation Creating a World Class Afib Platform April 2020 1 © 2020 AtriCure, Inc. All rights reserved. AtriCure"
01/13/2020 8-K Investor presentation
Docs: "AtriCure Investor Presentation Creating a World Class Afib Platform January 2020 © 2020 AtriCure, Inc. All rights reserved. AtriCure 1"
08/12/2019 8-K Investor presentation, Acquisition/merger/asset purchase announced
Docs: "FORM 8-K",
"Agreement and Plan of Merger, among SentreHEART, Inc., AtriCure, Inc., Stetson Merger Sub, Inc., Second Stetson Merger Sub, LLC and Shareholder Representative Services LLC, as Securityholder Representative",
"Second Amendment to Loan and Security Agreement among AtriCure, Inc., Silicon Valley Bank, and the other parties named therein",
"AtriCure Enters into Definitive Agreement to Acquire SentreHEART",
"Investor Presentation—Transaction Overview"
01/07/2019 8-K Investor presentation
Docs: ",",
","
01/08/2018 8-K Investor presentation
08/18/2017 8-K Quarterly results
01/09/2017 8-K Form 8-K - Current report
01/11/2016 8-K Investor presentation
Docs: "AtriCure Announces Preliminary Results for Fourth Quarter and Full Year 2015 Updates 2016 Guidance",
"AtriCure, Inc. Forward Looking Statements/Non-GAAP Measures"
01/12/2015 8-K Investor presentation
Docs: "AtriCure Announces Preliminary Results for Fourth Quarter and Full Year 2014 Issues 2015 Guidance",
"Investor Presentation"
01/07/2013 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy